Clinical Trials on Neurobehavioral Manifestations in Australia

Total 799 results

GlaxoSmithKline

Completed

FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers

Gastroparesis

Australia
Cochlear
Avania

Not yet recruiting

Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users (RECONNECT)

Hearing Loss, Conductive | Hearing Loss, Mixed Conductive-Sensorineural

Australia
Kira Pharmacenticals (US), LLC.

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Paroxysmal Nocturnal Hemoglobinuria

Australia
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Adult Attention-deficit Hyperactivity Disorder (ADHD)

Australia
Boehringer Ingelheim

Completed

Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome

Restless Legs Syndrome

Austria
Abbott Medical Devices

Completed

Study of Gemini Rechargeable Spinal Cord Stimulation (SCS) System

Chronic Pain

Australia
Fruithy Medical Pty Ltd

Completed

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of HYR-PB21 in Healthy Volunteers

Acute Postoperative Pain

Australia
New York State Institute for Basic Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Unknown

Vitamin E in Aging Persons With Down Syndrome

Alzheimer Disease | Down Syndrome

United States, Canada, Australia, United Kingdom
dorsaVi Ltd
Monash University

Completed

A Prospective Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain

Low Back Pain

Australia
Novartis Pharmaceuticals

Terminated

Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome

Fragile X Syndrome

Germany, United States, Switzerland, Australia, Canada, Denmark, France, Italy, United Kingdom, Spain
Melbourne Health
Eastern Health

Completed

The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor

Multiple Sclerosis | Tremor

Australia
The Bionics Institute of Australia

Recruiting

Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)

Hearing Impairment

Australia
ElectroCore INC

Terminated

Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy

Seizure

Australia
Cochlear
The Hearing Cooperative Research Centre; Royal Victoria Eye and Ear Hospital

Completed

Intracochlear Potentials: Volta Study (CLTD5663)

Hearing Loss

Australia
Cochlear
The Hearing Cooperative Research Centre; The Shepherd Centre

Completed

FLI Normative Study (FLI-P)

Hearing Loss

Australia
Cochlear
The Hearing Cooperative Research Centre; Royal Victoria Eye and Ear Hospital

Completed

CHANGE Feasibility Study (CLTD5626)

Hearing Loss

Australia
Cochlear

Completed

Clinical Evaluation of Bass and Treble Controls for CI Subjects (CLASS)

Hearing Loss

Australia
NeuroVia, Inc.

Withdrawn

Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy

X-Linked Adrenoleukodystrophy

Australia, Argentina, United Kingdom, Colombia, Chile, France, Russian Federation, Ukraine
Zynerba Pharmaceuticals, Inc.

Enrolling by invitation

Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

Fragile X Syndrome

United States, United Kingdom, New Zealand, Australia
Krankenhaus Barmherzige Schwestern Linz

Terminated

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Solid Tumours | Adjuvant Chemotherapy | Port-A-Cath

Austria
St George Hospital, Australia
St George & Sutherland Medical Research Foundation

Unknown

A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain (SCIATICA)

Acute Sciatica

Australia
Novartis Pharmaceuticals

Terminated

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Fragile X Syndrome

United States, Belgium, Australia, Israel, Switzerland, Germany, Denmark, Italy, Netherlands, Spain, Sweden, United Kingdom, France
University of Western Sydney
University of Auckland, New Zealand

Recruiting

Body Surface Gastric Mapping in Patients on Semaglutide

Gastroparesis | Semaglutide-Induced Gastric Motility

Australia
University Health Network, Toronto

Completed

Acetaminophen for Cancer Pain

Pain | Cancer

Canada, Australia
Bod Australia
Woolcock Institute of Medical Research

Completed

The CANabidiol Use for RElief of Short Term Insomnia (CANREST)

Insomnia | Sleep Disturbance | Insomnia Type; Sleep Disorder | Insomnia, Transient | Insomnia Due to Anxiety and Fear | Insomnia Due to Other Mental Disorder

Australia
Cochlear
Statistiska Konsultgruppen

Completed

Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System

Hearing Loss

Australia, Hong Kong
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome

Fragile X Syndrome

United States, Switzerland, Germany, Australia, Canada, Denmark, France, Italy, Spain, United Kingdom
Avigen

Completed

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain

Diabetic Neuropathy

Australia
Merz Therapeutics GmbH

Completed

Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool (I-REFER)

Post-stroke Spasticity

Austria
The Bionics Institute of Australia

Not yet recruiting

EarGenie MVP Performance Evaluation

Hearing Impaired Children

Australia
Medical University of Graz

Recruiting

Microbiome and Sarcopenia in Patients With Liver Cirrhosis

Liver Cirrhosis | Sarcopenia

Austria
University of Melbourne

Completed

Pelvic Floor Muscle Training for Incontinence in Older Women.

Stress Urinary Incontinence

Australia
The University of Queensland

Completed

The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease (CuePed)

Gait Disorders, Neurologic

Australia
Allergan

Terminated

Safety and Efficacy of AGN201781 in Neuropathic Pain

Neuralgia

Germany, Australia
Melbourne Health

Completed

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

Diabetic Nephropathy | Proteinuria | Glomerulonephritis | Kidney Disease

Australia
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Tetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis Vaccines

Australia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients (RLS)

Idiopathic Restless Legs Syndrome

United States, Spain, Finland, Italy, Germany, Sweden, Austria, Netherlands, United Kingdom
Cochlear

Completed

Clinical Evaluation of a Cochlear Implant System

Sensorineural Hearing Loss

Australia
Cochlear

Completed

Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor

Conductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing Loss

Australia
Woolcock Institute of Medical Research

Recruiting

Digital Sleep Therapy for Older Adults With Cognitive Impairment (ExCEED)

Cognitive Impairment | Insomnia Type; Sleep Disorder

Australia
Boston Scientific Corporation

Completed

Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain

Chronic Pain

Spain, Belgium, Australia
Bayside Health

Unknown

Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata

Uterine Fibroids

Australia
Cochlear

Completed

An Actual Use, Open-label Study Assessing Usability of Remote Assist to Program Cochlear Implant Recipients (RAL)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

Australia
Shire

Completed

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment (AIM-IT)

Hunter Syndrome

Spain, United States, Canada, United Kingdom, France, Australia, Mexico
Charles Darwin University

Completed

Kegel Exercises for Stress Urinary Incontinence

Urinary Incontinence,Stress

Australia
Allergan

Terminated

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Spasmodic Torticollis

Argentina, India, Australia
Cochlear
Avania; QbD Clinical

Recruiting

Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation (CALOS4)

Hearing Loss

Germany, Australia
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome

Fragile X Syndrome

United States, Belgium, Australia, Israel, Switzerland, Germany, France, Canada, Denmark, Indonesia, Italy, Netherlands, Spain, Sweden, Turkey, United Kingdom
Cerecin

Active, not recruiting

Tricaprilin Infantile Spasms Pilot Study

Infantile Spasm

Singapore, Australia
GlaxoSmithKline

Completed

The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder

Overactive Bladder

Australia

Clinical Trials on Neurobehavioral Manifestations in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations